Comment
doi: 10.1016/0140-6736(90)91985-j.
GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction?
- PMID: 1974965
- DOI: 10.1016/0140-6736(90)91985-j
Item in Clipboard
Comment
GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction?
Lancet.
.
No abstract available
Comment on
-
GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.Lancet. 1990 Jul 14;336(8707):65-71. Lancet. 1990. PMID: 1975321 Clinical Trial.
-
In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.Lancet. 1990 Jul 14;336(8707):71-5. Lancet. 1990. PMID: 1975322 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
